Trials / Withdrawn
WithdrawnNCT03304990
Panomics Relationships in the Epidemiology of Cancer Through In Silico Expression (PRECISE)
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Greater Baltimore Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
PRECISE is a study to discover new detection, prognosis and treatment biomarkers for cancer. This is a prospective, multi-center, observational study designed to collect de-identified biospecimens and clinical data from a large cohort of participants from clinical research networks in the United States. In this study, the investigators propose creating a large-scale normalized panomics dataset specifically designed for deep learning-based in silico analysis for biomarker discovery.
Detailed description
This study will enroll all subjects who are eligible and willing to participate with a goal of enrolling at least 10,000 in several categories: (i) Patients with Family History of Cancer, (ii) Patients with Clinical and Environmental Risk Factors for Cancer, and (iii) Patients with a Suspected or Confirmed Diagnosis of Cancer.
Conditions
- Cancer
- Patients With Clinical and Environmental Risk Factors for Cancer
- Patients With a Suspected or Confirmed Diagnosis of Cancer
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Patients with CA or suspected risk of CA or a family Hx | Patients with Family History of Cancer, (ii) Patients with Clinical and Environmental Risk Factors for Cancer, (iii) Patients with a Suspected or Confirmed Diagnosis of Cancer. |
Timeline
- Start date
- 2018-11-29
- Primary completion
- 2019-01-01
- Completion
- 2019-01-01
- First posted
- 2017-10-09
- Last updated
- 2020-07-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03304990. Inclusion in this directory is not an endorsement.